These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21716050)
1. Differences in cervical cytologic and histologic findings between women using depot-medroxyprogesterone acetate and oral contraceptives. Clark MK; Stockdale CK; Railsback L; Nichols S J Low Genit Tract Dis; 2011 Jul; 15(3):219-23. PubMed ID: 21716050 [TBL] [Abstract][Full Text] [Related]
2. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Harris TG; Miller L; Kulasingam SL; Feng Q; Kiviat NB; Schwartz SM; Koutsky LA Am J Obstet Gynecol; 2009 May; 200(5):489.e1-8. PubMed ID: 19375566 [TBL] [Abstract][Full Text] [Related]
3. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705 [TBL] [Abstract][Full Text] [Related]
4. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica. Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059 [TBL] [Abstract][Full Text] [Related]
5. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under. Hoyo C; Cousins DS; Bisgrove EZ; Gaines MM; Schwingl PJ; Fortney JA West Indian Med J; 2004 Dec; 53(6):406-12. PubMed ID: 15816269 [TBL] [Abstract][Full Text] [Related]
6. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Jeng CJ; Liang HS; Wang TY; Shen J; Yang YC; Tzeng CR Int J Gynecol Cancer; 2003; 13(4):518-21. PubMed ID: 12911731 [TBL] [Abstract][Full Text] [Related]
7. Depot medroxyprogesterone acetate: a risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia? Martirosian TE; Smith SC; Baras AS; Darracott MM J Low Genit Tract Dis; 2010 Jan; 14(1):37-42. PubMed ID: 20040834 [TBL] [Abstract][Full Text] [Related]
8. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681 [TBL] [Abstract][Full Text] [Related]
9. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception; 1992 Apr; 45(4):299-312. PubMed ID: 1387601 [TBL] [Abstract][Full Text] [Related]
10. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Sawaya GF; Grady D; Kerlikowske K; Valleur JL; Barnabei VM; Bass K; Snyder TE; Pickar JH; Agarwal SK; Mandelblatt J Ann Intern Med; 2000 Dec; 133(12):942-50. PubMed ID: 11119395 [TBL] [Abstract][Full Text] [Related]
11. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502 [TBL] [Abstract][Full Text] [Related]
12. Histologic findings from the cervix among older women with abnormal cervical cytology. Massad LS; Behbakht K; Collins YC; Cejtin HE Gynecol Oncol; 2003 Mar; 88(3):340-4. PubMed ID: 12648584 [TBL] [Abstract][Full Text] [Related]
13. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand. Colli E; Tong D; Penhallegon R; Parazzini F Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866 [TBL] [Abstract][Full Text] [Related]
14. Hormonal contraception and false-positive cervical cytology: is there an association? Hoekstra AV; Kosinski A; Huh WK J Low Genit Tract Dis; 2006 Apr; 10(2):102-6. PubMed ID: 16633239 [TBL] [Abstract][Full Text] [Related]
15. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Thomas DB; Ray RM Contraception; 1995 Nov; 52(5):307-12. PubMed ID: 8585888 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of atypical glandular cells of undetermined significance. Geier CS; Wilson M; Creasman W Am J Obstet Gynecol; 2001 Jan; 184(2):64-9. PubMed ID: 11174481 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247 [TBL] [Abstract][Full Text] [Related]
18. Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate. Valente PT; Schantz HD; Trabal JF Cancer; 1998 Dec; 84(6):328-34. PubMed ID: 9915133 [TBL] [Abstract][Full Text] [Related]
19. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Vessey MP; Lawless M; McPherson K; Yeates D Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502 [TBL] [Abstract][Full Text] [Related]